Federal award
KBR WYLE SERVICES, LLC
0135
Contract
Obligated and Ceiling
- Obligated (net)
- $4,600,357.95
- Ceiling (potential value, not spending)
- $23,196,323.00
- Current value
- $23,196,323.00
- Gross positive obligations
- $4,705,076.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- KBR WYLE SERVICES, LLC · KNV8E5VRLHT9
- Owner company
- KBRBasis reviewed link: a dated, evidenced ownership link.
- Reported parent
- KBR, INC. · VJ3XVZC76HT9
- Awarding agency
- Department of Defense · sub-agency 9763 · office S0107A
- Funding agency
- Department of Defense · sub-agency 5700
- Product or service (PSC)
- AZ12 · R&D- OTHER RESEARCH AND DEVELOPMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Industry (NAICS)
- 541710 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES
- PIID
- 0135
- Parent vehicle (IDV PIID)
- HC104705D4005
- Award type code
- C
- Actions
- 13 · Apr 29, 2010 to Jan 30, 2019
- Why it is listed
- gross positive obligations of $100k or more (contracts); reviewed company, $10k or more
Action History13
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jan 30, 2019 | FY2019 | 1B | C | −$73,486.63 | |
| Mar 21, 2018 | FY2018 | 1A | C | −$31,231.42 | |
| Dec 3, 2013 | FY2014 | 10 | B | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 7, 2013 | FY2013 | 9 | C | $162,630.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 30, 2013 | FY2013 | 8 | C | $260,928.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jun 19, 2013 | FY2013 | 7 | C | $100,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 4, 2013 | FY2013 | 6 | B | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Dec 5, 2012 | FY2013 | 5 | C | $480,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 10, 2012 | FY2012 | 4 | C | $375,233.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 7, 2011 | FY2011 | 3 | C | $1,707,620.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jun 21, 2011 | FY2011 | 2 | C | $395,656.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 18, 2010 | FY2010 | 1 | C | $744,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 29, 2010 | FY2010 | 0 | — | $479,009.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.